Consuming soy greatly helps people who are prone to bone fractures and prevents them from suffering from all kinds of bone problems. We recommend menopausal women and middle-aged women to consume more soy in their food.
New studies by researchers confirm the therapeutic effect of soy in osteoporosis. Soy contains a chemical compound called isoflavone, which has a function similar to estrogen and can protect bones.
Studies by researchers at the University of Hull in England show that the proteins and isoflavones in soy prevent osteoporosis in postmenopausal women.
In osteoporosis, the bones become porous. The microscopic structure of bones is honeycomb.
Pores and houses in cancellous bone are much larger than in healthy bone. In this case, the bones gradually lose their mass and density and become very sensitive and fragile.
This disease has no initial symptoms and occurs when one of the bones (usually the hip and wrist bones) breaks.
Every year, about 9 million bones are broken due to osteoporosis; That is one bone every three seconds, which is a terrible statistic. Osteoporosis is more severe and common in postmenopausal women due to the cessation of estrogen hormone secretion.
Research shows that soybeans contain a chemical compound called isoflavones. Isoflavone has an estrogen-like function and can protect bones.
In this study, it is stated that consumption of soy and isoflavone supplements, in addition to preventing osteoporosis, improves the function of the cardiovascular system.
Osteoporosis affects one in three women and one in five men over the age of 50. Inactivity, lack of calcium-containing substances, reduction of vitamin D in the body, certain diseases such as cancer, use of steroid drugs, early menopause (less than 45 years old), smoking, reduction of estrogen in the body, special medical conditions such as Hyperthyroidism, celiac disease, chronic kidney failure, rheumatoid arthritis, chronic liver diseases and type one diabetes are the most important causes of osteoporosis.
The results of this research were presented at the annual endocrinology conference in Edinburgh.
